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Research
eighth leading cause of death,1 and 250 000
episodes associated with central venous cath-
eters (CVCs) are estimated to occur there
annually.3 In Australia in the early 1990s,
about 2% of ll CVCs and 0.04% of periph-
eral venous catheters were associated with








Objective:  To evaluate a hospital-wide surveillance and intervention program 
introduced to reduce the incidence of bloodstream infections (BSIs) caused by 
intravascular (IV) catheters.
Design, setting and participants:  Prospective surveillance of all inpatients and 
outpatient attendees with positive blood cultures (both hospital-onset and 
unity-onset) at a 500-bed tertiary referral hospital from 1998 to 2005.
ventions:  Prompt review of all positive blood cultures with identification of BSIs 
o IV catheters and associated preventable factors; weekly team meetings and 
lar reports to clinical areas, with assistance to implement targeted interventions.
 outcome measure:  Number of BSI episodes due to IV catheters per year.
lts:  There were 491 BSI episodes due to IV catheters, mainly central venous 
ters. Episodes per year fell from 110 in 1998 to 48 in 2005 (from 32% of all BSI 
episodes to 14%; a > 50% reduction). From 1998 to 2005, the rate per 1000 discharges 
fell from 2.3 to 0.9 (P for trend < 0.0005) and the rate per 1000 patient-days fell from 0.6 
to 0.3 (P for trend < 0.0005).
Conclusions:  Our program was associated with a profound drop in the number of IV 
catheter-related BSIs per year. Active surveillance and intervention programs can lead to 
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substantial and sustained reductions in these common life-threatening infections.an
ca
thM y commonly occurring healthre-associated infections are life-reatening, especially bloodstream
infections (BSIs).1,2 Intravascular (IV) cath-
eters are the most frequent cause of BSIs,
most of which are preventable.3-8
In the United States, BSIs are now the
BSI episodes per year and an average rate of
1.6 per 1000 admissions in Australian teach-
ing hospitals.4 More recently in England, this
rate was 2.3 per 1000 admissions in teaching
hospitals and 0.9 per 1000 admissions in
non-teaching hospitals.7 The reported mor-
tality associated with BSIs is variable,3 but in
the US even a low rate of attributable mortal-
ity of 10% translates to 25 000 deaths per
year.
Ongoing surveillance of BSIs associated
with IV catheters is patchy. Available “whole
of hospital” data show that IV catheters
account for 30% or more of BSIs in Australia,
England and the US.5-7,9 Data collection and
surveillance of BSIs has been recommended,
but primarily for intensive care units
(ICUs),10,11 even though most CVCs are used
outside ICUs.12
To prevent the occurrence of BSIs and
improve management practices, we imple-
mented a hospital-wide surveillance and
intervention program.
METHODS
Canberra Hospital is a 500-bed tertiary refer-
ral hospital offering most medical and surgi-
cal services for a population of over 550 000.
In 1990, the hospital’s rate of IV catheter-
related BSIs was 1.7 per 1000 discharges.4
We used a quality assurance grant to
employ a full-time nurse and a part-time data
entry clerk (0.2 full-time equivalent [FTE]),
and to purchase computer hardware and
software. A part-time nurse (0.6 FTE) was
employed once the program was established
(total recurrent costs per annum of about
A$60 000). Our surveillance study ran for 8
years, from 1998 to 2005.
The project nurse visited the microbiology
laboratory daily to review all BSI episodes
(both hospital- and community-onset) after
receiving notification of positive blood cul-
tures. The nurse also visited wards to obtain
episode details from the patient, the caring
medical and nursing staff, and medical
records. Episodes were categorised using
national definitions.13 IV catheter-related
BSIs and primary health care-associated
bacteraemias were categorised using US
Centers for Disease Control and Prevention
definitions.3 At Day 7 or earlier if discharged,
the patient’s outcome (alive or not) and the
contribution of sepsis to mortality or ongoing
morbidity were assessed.
A multidisciplinary team reviewed the clin-
ical details of all new positive blood culture
results at a 30-minute weekly meeting. Par-
ticular attention was paid to any episode
potentially associated with IV catheter sepsis
or preventable causes.
Data were obtained from the hospital’s
financial and activity reports for occupied
bed-days (here referred to as “patient-days”)
and separations (“discharges”) and included
day-only patients. Trends in the annual rate
of BSIs per patient-days and discharges were
estimated by aggregating data for BSIs,
patient-days and discharges for each calendar
year. Rates were modelled in Stata (Stata-
Corp, College Station, Tex, USA) using log
linear regression of the number of BSIs, with
the logarithm of the number of patient-days
or discharges as the offset term. Year was
fitted as a linear term to assess whether there
was a trend, but without modelling the trend
itself. Significance of the regression term was
assessed using a likelihood ratio test at the
5% level. Rate ratios for 2005 versus 1998
were calculated using the fitted values for the
number of BSIs.
This study was a quality assurance pro-
gram but was also approved by the ACT
Health Human Research Ethics Committee.
RESULTS
Over the 8-year period, there were 491 BSI
episodes caused by IV catheters, with a
greater than 50% reduction during the study,
from 110 episodes in 1998 to 48 in 2005
(Box 1, Box 2). From 1998 to 2005, the rate
of IV catheter-related episodes fell from 2.3 to
0.9 per 1000 discharges (P for trend
< 0.0005), and from 0.6 to 0.3 per 1000
patient-days (P for trend < 0.0005). The rate
ratio was 0.35 (95% CI, 0.26–0.46) for dis-
charges and 0.36 (95% CI, 0.27–0.48) for
patient-days.A • Volume 187 Number 10 • 19 November 2007 551
RESEARCHAlthough the number of episodes in each
3-month period fluctuated, there was an
overall downward trend from the beginning
to the end of the project (Box 2). Episodes of
IV catheter sepsis resulted in 4% mortality
(20/491 episodes) by Day 7. A subgroup of
44 patients with IV catheter sepsis in 2000–
2001 was followed for 6 months, and had a
cumulative mortality of 4% at Day 7, 12% at
1 month, and 39% at 6 months.
CVCs were the most common IV catheters
associated with BSIs (Box 1). However, all
catheter types were implicated, including
short peripheral catheters and peripherally
inserted central catheters (PICC lines).
IV catheter sepsis occurred in all areas of
the hospital (Box 3), but the numbers in each
unit varied from year to year. In 2004, there
were 1238 CVCs, 617 PICC lines and 27 683
peripheral catheters purchased, with BSI rates
of 8.8 per 1000 CVC catheters (0.9%), 4.9
per 1000 PICC lines (0.5%), and 0.25 per
1000 peripheral catheters (0.03%).
Staphylococcus aureus (methicillin-sensitive
and methicillin-resistant) was the most com-
mon organism involved in IV sepsis, followed
by coagulase-negative staphylococci and
Candida spp. (Box 4). Comparing 1998–2001
with 2002–2005, the largest percentage falls
were with S. aureus, coagulase-negative
staphylococci, and gram-negative rods.
In 1998, IV catheters were the most com-
mon primary site for sepsis when all BSI
episodes from any cause were examined,
accounting for 110 of the 339 significant
episodes (32%) (Box 5). After 2002, IV cath-
eters were no longer the commonest cause of
BSIs; by 2005 they had decreased to be the
third most common primary site (48/341
episodes; 14%) after gastrointestinal tract and
genitourinary tract episodes. Primary health
care-related episodes (ie, all IV and all
“unknown” primary site BSIs) dropped from
128 episodes in 1998 to 87 in 2005 (Box 5).
In 2005, this was a rate of 1.7 per 1000
discharges; down 38% from 1998.
DISCUSSION
The decline in IV catheter-related BSIs was
associated with multiple interventions. Indi-
vidual units instigated many of these, usually
in consultation with the infection control
service after receiving feedback and advice
about their rates and numbers of IV-related
BSIs (Box 6). We believe our surveillance
program was the catalyst for many of these
interventions, which may otherwise have
been introduced later or not at all.
The project nurse’s ward visits to discuss
each BSI episode with the medical and nurs-
ing staff provided prompt feedback. This
interaction and the collection and feedback of
other data allowed the units to “buy in” to the
problem. We believe the combined interac-
tion of all these program elements resulted in
the dramatic reduction in sepsis observed; a
point also made by others.10 Reliable and
regular reporting of results also sustained
enthusiasm for ongoing vigilance.
Passive surveillance based on medical and
laboratory records alone is unlikely to have
achieved the same positive outcomes. With
its associated time lag, passive surveillance is
also likely to have been much less accurate in
identifying the primary sites for sepsis or
patient outcome. Studies in ICUs in the US,
Germany, Brazil, Australia and Switzerland
have shown that active surveillance and inter-
ventions can substantially reduce the number
of BSIs caused by IV catheters.8,10,11,14-18 Our
study confirms the findings of Meier et al19
that this can also be done for the whole
hospital.
1 Number of bloodstream infection episodes associated 
with each intravascular (IV) device type, by year
IV device type 1998 1999 2000 2001 2002 2003 2004 2005 Total
CVC 50 35 25 17 19 14 11 15 186
Hickman 25 7 14 16 1 2 5 5 75
Vascath 18 6 15 10 7 5 4 5 70
SPV 6 3 7 2 3 1 7 7 36
Umbilical 3 3 2 1 3 8 4 3 27
Gortex loop 2 9 5 1 1 0 2 2 22
Longline 2 1 8 0 2 2 2 1 18
Portacath 1 7 1 2 0 2 4 3 20
PICC 0 0 2 5 1 11 3 6 28
Other* 3 1 2 0 2 0 0 1 9
Total 110 72 81 54 39 45 42 48 491
* Arterial catheters, 3; arteriovenous fistula, 2; temporary pacemakers, 2; Swan–
Ganz catheter, 1; femoral sheath, 1. CVC = central venous catheter. SPV = short 
peripheral venous. PICC = peripherally inserted central catheter.  ◆
2 Rate of intravascular (IV) device-related bloodstream 
infection episodes per 1000 discharges, 1998–2005*
Trendline data: y = − 0.5946ln(x) + 2.7805. * In 1990, the rate was 1.7/1000 
discharges.4 ICU = intensive care unit. TPN = total parenteral nutrition. ◆
0
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2001 – ICU “retention by exception”
policy. Reduced TPN usage
Increased incidence in neonatal ICU
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Adult ICU 16 2 31
Surgical services (other) 8 9 32
Gastroenterology* 7 12 38
Medical oncology 26 3 44
Neonatal ICU 10 11 51
Medical services (other) 20 13 58
Renal 32 10 75
Haematology 43 16 103
Total 182 90 491
* Frequently associated with total parenteral 
nutrition. ICU = intensive care unit. ◆552 MJA • Volume 187 Number 10 • 19 November 2007
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sodes occurring per year in our hospital than
when the program started. This is likely to
represent a saving of six or more lives per
year (assuming at least 10% attributable mor-
tality). Each IV catheter-related BSI episode
also has significant financial costs. Measuring
these is beyond the scope of this study, but a
South Australian study found that each case
of S. aureus bacteraemia may be associated
with additional health care costs of about
A$20 000.20 In the US, the attributable cost
of each CVC-associated BSI episode (from all
organisms) is estimated at US$34 508–
$56000.3 Using the most conservative of
these estimates, if 60 bacteraemia cases are
prevented each year, and at least 15 of these
are due to S. aureus, then annual hospital cost
savings will be at least A$300000. However,
a more realistic estimate is over a million
dollars per year. This is offset by the net
additional cost of the program (about
A$60 000 per year).
Our rate per 1000 patient-days for primary
nosocomial BSIs fell 34% from 0.8 in 1998 to
0.5 in 2005. A study in a 200-bed hospital in
Iowa found a similar decrease in primary BSIs
(35%) after the introduction of an 11-mem-
ber IV team (from 1.1 to 0.7 per 1000
patient-days).19 We were able to sustain a
large reduction in IV-related sepsis, over a
longer study period and at a much lower cost
than with a full IV team.
Our data show the value of an ongoing
surveillance program. On several occasions
during the study we saw rising rates and then
“peaks” in sepsis (Box 2). One was in 2003 in
the neonatal ICU and prompted a complete
review of their IV catheter-related proced-
ures. We never determined the cause of this
increase, but believe its early detection, in
conjunction with the staff reviewing proto-
cols and enacting changes, resulted in its
resolution. The same benefit was noted with
another peak in 2004 after the introduction
of a new mechanical valve needleless IV
system and new mechanical pumps. Similar
increases of IV sepsis with use of these sys-
tems have been reported in the US.21 After an
extensive education program at our hospital,
IV sepsis rates returned to lower levels.
Programs that use only denominators such
as “catheter line-days” and focus on ICUs are
inappropriate. Whole-of-hospital programs
should be implemented to capture all BSI
episodes, with denominators that are easier to
collect (eg, episodes per 1000 discharges or
patient-days).7,8 Sepsis rates expressed only
as catheter line-days do not acknowledge
timely removal of lines and thus removal of
risk,14 and may lead to continued overuse of
these catheters and help to hide the numbers
of episodes that occur.
The initial rate of IV sepsis in our hospital
was reasonably low by most Australian4 and
international comparisons.3 Our ICU rates
were lower than those reported for compar-
able units in New South Wales (1.8 v 3.7 per
1000 line-days)14,22 and than the average
ICU rate in the US (5.3 per 1000 line-days for
CVCs).3 Our study shows that a surveillance
and intervention program can decrease BSI
episodes even in hospitals with relatively low
rates of sepsis. We believe that over 75% of
episodes that still occur are due to preventa-
ble factors. Thus, the baseline number of
“unavoidable” BSIs due to IV catheters should
5 Rates of intravascular (IV) catheter sepsis and hospital admission details, by year
1998 1999 2000 2001 2002 2003 2004 2005
Total significant episodes* 339 308 318 289 272 316 354 341
Total indeterminate episodes 35 37 37 36 31 32 25 35
Total contaminant episodes 245 200 197 197 217 210 235 266
Total positive blood cultures 619 545 552 522 520 558 614 642
IV catheter-related episodes 110 72 81 54 39 45 42 48
Health care-related primary 
bacteraemia
128 111 106 92 73 75 71 87
Total significant episodes 
excluding IV catheters
228 235 239 234 232 271 312 291
Discharges 46 656 47 454 49 090 49 606 49400 50 805 48 655 51 122
Rate per 1000 discharges of:
Total significant episodes 7.2 6.5 6.5 5.8 5.5 6.2 7.2 6.6
Total significant episodes 
excluding IV catheters
4.9 5.0 4.9 4.7 4.7 5.3 6.4 5.7
IV-related episodes† 2.3 1.5 1.7 1.1 0.8 0.9 0.9 0.9
Patient-days‡ 171 455 164 027 166 537 170 285 170 661 173 833 171 173 177239
Rate per 1000 patient-days of:
Total significant episodes 2.0 1.9 1.9 1.7 1.6 1.8 2.1 1.9
Total significant episodes 
excluding IV catheters
1.3 1.4 1.4 1.4 1.4 1.6 1.8 1.6
IV-related episodes 0.6 0.4 0.5 0.3 0.2 0.3 0.2 0.3
* Includes all bloodstream infection episodes treated and diagnosed at the hospital (ie, all community- and 
hospital-onset from all causes). † In 1990, the rate was 1.7/1000 discharges.4 ‡ Includes day-only patients. ◆
4 Number of microorganisms causing intravascular catheter-related 
bloodstream infection episodes, by year
Microorganism* 1998 1999 2000 2001 2002 2003 2004 2005 Total (%)
Staphylococcus aureus 26 30 29 20 20 14 13 13 165 (31%)
Methicillin-sensitive 24 25 19 16 14 11 11 10 130 (25%)
Methicillin-resistant 2 5 10 4 6 3 2 3 35 (7%)
Coagulase-negative 
staphylococci 
42 14 24 9 8 22 8 11 138 (26%)
Candida spp. 8 1 4 4 1 0 8 8 34 (6%)
Klebsiella spp. 7 3 6 7 1 3 1 3 31 (6%)
Stenotrophomonas 
maltophilia
6 8 2 3 0 1 2 1 23 (4%)
Enterobacter spp. 4 2 5 4 1 1 2 0 19 (4%)
Escherichia coli 2 2 1 1 2 0 4 0 12 (2%)
Pseudomonas spp. 4 3 3 3 2 0 2 4 21 (4%)
Other† 17 14 11 6 7 7 10 12 84 (16%)
Total 116 77 85 57 42 48 50 52 527 (100%)
* In 31 episodes, there was more than one significant organism isolated. † The most common “other” isolates 
were: Viridans streptococci, 12; Acinetobacter spp., 10; Proteus spp., 10; Enterococcus spp., 10; Serratia spp., 
8; and Corynebacterium jeikeium, 4. ◆MJA • Volume 187 Number 10 • 19 November 2007 553
RESEARCHbe only about 15 episodes per year, or 0.2 per
1000 discharges.
A similar approach can be put into place in
most hospitals. Our surveillance and inter-
vention program is relatively inexpensive and
likely to be extremely cost-effective. Programs
such as this should result in a major reduc-
tion in IV catheter-related sepsis.
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6 Interventions for intravascular (IV) catheter-related bloodstream infections (BSIs)
Intervention Hospital units
Prospective surveillance of BSIs Hospital-wide
Subcutaneous tunnelling of Vascath catheters Renal medicine
Central venous catheter (CVC) “retention by exception”* Intensive care unit (ICU)
Prevention of septic flush by correct use of alcohol antiseptics Oncology, haematology
Monitoring of peripheral IV policy compliance Aged care, general surgery
Patient information pamphlet for CVC care Hospital-wide, community
Introduction of alcoholic chlorhexidine skin prep for IV insertions Hospital-wide
Reduction in the use of total parenteral nutrition Hospital-wide
Notification of each IV catheter-related BSI to specialist in charge 
of patient by letter outlining current hospital policies and pointing 
out potential breaches in the episode
Hospital-wide, medical 
officer 




Dissemination of BSI project information Hospital-wide, GPs, media
* The CVC was routinely removed when the patient left the ICU unless a specific and appropriate reason could 
be identified and documented to justify its continued retention (see references14,15 for more details). ◆554 MJA • Volume 187 Number 10 • 19 November 2007
